$34.670
-2.260 (-6.52%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de COGT por análisis de gráficos similares
Alphio's COGT stock price prediction model matches the current Cogent Biosciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $34.36 (-0.88%). The 1-week path is $32.74 (-5.58%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Cogent Biosciences Inc?
Cogent Biosciences Inc is a good buy right now due to its promising pipeline, particularly the NDA submission for Bezuclastinib, which has shown significant efficacy in clinical trials. The current price of $34.67 is well below the analyst price target of $52, suggesting a potential upside of 50%. Additionally, the RSI is at 27.571, indicating that the stock is oversold and may be due for a rebound. However, the main risk is the company's ongoing net losses, with a net income of -88,932,000 USD in Q2 2026, which could impact future performance if not addressed.
COGT cerró en $34.67 el Friday, tras bajar -6.52%
Cogent Biosciences Inc (COGT) last closed at $34.67, losing -6.52%. These facts feed the 1-day and 1-week COGT price prediction above.
Consenso de analistas
Cogent Biosciences Inc (COGT): 3 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Cogent Biosciences Inc (COGT) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de COGT, ordenadas por similitud.
Análisis de estacionalidad de COGT
Historically the probability of a positive August return for COGT is 98.41%. September offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de COGT
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $8.76 | $11.15 | $12.33 | -67.85% |
| Sep 2026 | $13.46 | $15.07 | $16.66 | -56.52% |
| Oct 2026 | $10.75 | $11.15 | $13.16 | -67.85% |
| Nov 2026 | $11.88 | $15.08 | $16.50 | -56.50% |
| Dec 2026 | $10.02 | $11.72 | $13.42 | -66.20% |
En 2026, se proyecta que Cogent Biosciences Inc (COGT) oscile entre $8.76 y $16.66.
Previsión mensual de Cogent Biosciences Inc para 2026
En Aug de 2026, se proyecta que Cogent Biosciences Inc promedie $11.15, con un mínimo de $8.76 y un máximo de $12.33.
En Sep de 2026, se proyecta que Cogent Biosciences Inc promedie $15.07, con un mínimo de $13.46 y un máximo de $16.66.
En Oct de 2026, se proyecta que Cogent Biosciences Inc promedie $11.15, con un mínimo de $10.75 y un máximo de $13.16.
En Nov de 2026, se proyecta que Cogent Biosciences Inc promedie $15.08, con un mínimo de $11.88 y un máximo de $16.50.
En Dec de 2026, se proyecta que Cogent Biosciences Inc promedie $11.72, con un mínimo de $10.02 y un máximo de $13.42.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.